Hartmut Eimermacher
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 15
- Oncology 10
- Viral-associated cancers and disorders 4
- CAR-T cell therapy research 3
- Co-authors
- Wolfgang Hiddemann (11 shared papers)Michael Unterhalt (8 shared papers)Bernhard Wörmann (6 shared papers)Bernd Metzner (7 shared papers)Martin Dreyling (7 shared papers)Eva Hoster (5 shared papers)Ulrich Dührsen (5 shared papers)Hannes Wandt (4 shared papers)
- Journals
- Blood (10 papers)Annals of Hematology (4 papers)Journal of Clinical Oncology (3 papers)Leukemia (2 papers)Cancer (2 papers)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Hartmut Eimermacher
23 papers receiving 1.7k citations
Hartmut Eimermacher's Hit Papers
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 1.2k
- Genetics 585
- Hematology 337
- Oncology 707
- Neurology 114
Countries citing papers authored by Hartmut Eimermacher
This map shows the geographic impact of Hartmut Eimermacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Eimermacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Eimermacher more than expected).
Fields of papers citing papers by Hartmut Eimermacher
This network shows the impact of papers produced by Hartmut Eimermacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Eimermacher. The network helps show where Hartmut Eimermacher may publish in the future.
Co-authors
The 25 scholars most cited alongside Hartmut Eimermacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Hit paper breakdown → | 2007 | 632 |
| 2 | 2005 | 420 | |
| 3 | 2006 | 122 | |
| 4 | 2004 | 101 | |
| 5 | 2008 | 100 | |
| 6 | 1998 | 46 | |
| 7 | Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group. | 1996 | 41 |
| 8 | 2013 | 30 | |
| 9 | 1993 | 22 | |
| 10 | 2008 | 21 | |
| 11 | 2004 | 20 | |
| 12 | 2007 | 19 | |
| 13 | 2013 | 19 | |
| 14 | 1998 | 18 | |
| 15 | 1999 | 14 | |
| 16 | 2004 | 14 | |
| 17 | 2008 | 14 | |
| 18 | 1998 | 13 | |
| 19 | 2005 | 10 | |
| 20 | 2006 | 8 |
About Hartmut Eimermacher
Hartmut Eimermacher is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hematology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers), Acute Myeloid Leukemia Research (6 papers), Viral-associated cancers and disorders (4 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Genetics (585 citations), Hematology (337 citations), Oncology (707 citations) and Neurology (114 citations). Hartmut Eimermacher has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Wolfgang Hiddemann, Michael Unterhalt, Bernhard Wörmann, Bernd Metzner, Martin Dreyling, Eva Hoster, Ulrich Dührsen, Hannes Wandt, Joerg Hasford and Marcel Reiser. Their work appears in journals such as Blood, Annals of Hematology, Journal of Clinical Oncology, Leukemia and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.